Skip to content

NLP to Aid in the Evaluation and Diagnosis of FGIDs

Using Natural Language Processing of Novel Biopsychosocial Disease Constructs to Aid in the Evaluation and Diagnosis of Functional Gastrointestinal Disorders

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05501028
Enrollment
700
Registered
2022-08-15
Start date
2018-08-09
Completion date
2026-12-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Gastrointestinal Disorders

Brief summary

The study has two arms, where the same natural language processing (NLP) and probabilistic graphical modeling technology will be utilized on patients' report of symptoms in both arms. The clinical arm is focused on patients presenting for consultation with a gastroenterologist. The endoscopy arm is focused generally on patients presenting for a diagnostic endoscopy, with the goal of capturing Functional Gastrointestinal Disorder (FGID) patients prior to diagnosis.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER
Massachusetts Institute of Technology
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for consult in the Motility Clinic in the MGH Gastroenterology Unit or for diagnostic endoscopy in the MGH Gastroenterology Unit * Patient must agree to have their interactions audio-recorded * Informed consent form signed by the subjects

Exclusion criteria

* Non-native English speaker * Patients unable to communicate their own symptoms

Design outcomes

Primary

MeasureTime frameDescription
Latent themes present in patient descriptions of FGIDs symptoms08/09/2018-08/09/2023Latent themes present in patient descriptions of FGIDs symptoms as generated by machine learning as well as quantitative comparisons to traditional metrics of patient descriptions including Rome IV criteria and patient descriptions of severity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026